Description
Cyclin-dependent protein kinase inhibitors in breast cancer treatment
Article: Cyclin-dependent protein kinase inhibitors in breast cancer treatment
€3.03
Related products
-
Article: Highlights in digestive oncology
€3.03 Add to cart -
Article: Highlights in melanoma
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
1 year access Online Belgian Journal of Hematology (BJH)
€71.94 Add to cart
